2018年,国家药品监督管理局按照中共中央办公厅和国务院办公厅《关于深化审评审批制度改革鼓励药品医疗器械创新的意见》的要求,全面深化医疗器械审评审批制度改革,与国际接轨,夯实基础,科学要求,规范程序,着力在临床评价和创新医疗器械支持上发力,进一步激发产业活力,满足人民群众用械需求和安全需求。
<<In 2018,NMPA Comprehensively deepen medical device evaluation and approval reformation,according to the “Opinions on Deepening of medical device review and approval reform,encourage the innovation and development of Drug and Medical Device industry”,issued by General Office of the CPC Central Committee and General Office of the State Council,adopting international advanced experience,building the foundation of requirements for medical device supervision,setting scientific application requirements,standardizing procedures,focus on the clinical evaluation and supporting of innovation medical device,stimulating industry vitality,meet people’s demand for using advanced medical device and safty.
<<